Nattokinase Market 2025-32

Page 1


Report Overview

Nattokinase is a potent fibrinolytic enzyme extracted from Natto, a traditional Japanese fermented soybean dish made using Bacillus subtilis natto.

As a dietary supplement, nattokinase has gained considerable attention due to its cardiovascular benefits, particularly its ability to dissolve blood clots and improve circulation. The enzyme is believed to help reduce blood pressure, enhance blood flow, and support heart health, making it a preferred natural remedy for thrombotic disorders.

Nattokinase is widely used across the food additives and dietary supplements industries, and its growing popularity stems from a global shift towards natural and functional health products.

Market Analysis

The global Nattokinase Market was valued at approximately US$ 34.92 million in 2024 and is expected to expand at a Compound Annual Growth Rate (CAGR) of 10.24%, reaching US$ 67.61 million by 2031.

This impressive growth trajectory indicates a robust interest from consumers, especially within preventive healthcare and wellness circles.

Historical market data indicates consistent upward movement, with increasing consumer awareness regarding cardiovascular health and the benefits of natural supplements fueling demand.

Regional Analysis

North America

Europe

Asia-Pacific

South America

Middle East & Africa

Competitor Analysis

Kangdu Pharmaceutical Co., Ltd.
Xi'an Haoxuan Bio-Tech Co., Ltd.
Xi'an Longze Biotechnology Co., Ltd.
Shaanxi Jintai Biological Engineering Co., Ltd.
Shaanxi Fruiterco Biotechnology Co., Ltd.

5000Fu/g-10000Fu/g

10000Fu/g-20000Fu/g Others

Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.
Nattokinase Market 2025-32 by MarketResearch - Issuu